Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Share-based Compensation (2021 - 2025)

Silo Pharma (SILO) has disclosed Share-based Compensation for 4 consecutive years, with $52309.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation changed N/A to $52309.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57960.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $117021.0 for FY2025, N/A changed from the prior year.
  • Share-based Compensation hit $52309.0 in Q4 2025 for Silo Pharma, up from $1414.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $83728.0 in Q1 2021 to a low of $1414.0 in Q4 2023.
  • Historically, Share-based Compensation has averaged $30620.9 across 4 years, with a median of $25458.0 in 2022.
  • Biggest five-year swings in Share-based Compensation: plummeted 46.24% in 2022 and later tumbled 97.65% in 2023.
  • Year by year, Share-based Compensation stood at $83728.0 in 2021, then fell by 28.19% to $60122.0 in 2022, then crashed by 97.65% to $1414.0 in 2023, then soared by 3599.36% to $52309.0 in 2025.
  • Business Quant data shows Share-based Compensation for SILO at $52309.0 in Q4 2025, $1414.0 in Q4 2023, and $4237.0 in Q3 2023.